American Society of Hematology Annual Meeting & Exposition

newsroom

Featured

Podcast
Podcast
08/06/2024
Nirmish R. Shah, MD
In this podcast, Nirmish Shah, MD, discusses patient involvement and the use of patient-reported outcomes in the development of sickle cell disease interventions. Dr Shah’s team presented research on this...
08/06/2024
Video
Video
04/08/2024
Diana Abbott, PhD; Grace Bosma, MS
In this video, Diana Abbott, PhD, and Grace Bosma, MS, discuss their team’s study on the outcomes and intensity of first-line therapy for the treatment of diffuse large B-cell lymphoma (DLBCL) in elderly...
04/08/2024
Conference Coverage
Conference Coverage
02/23/2024
Anthony Calabro, MA
Researchers assessed the efficacy of venetoclax-based treatments for patients with relapsed/refractory chronic lymphocytic leukemia. This study was presented at the 65th ASH Annual Meeting & Exposition...
02/23/2024

Conference Coverage

Conference Coverage
Conference Coverage
02/23/2024
Anthony Calabro, MA
Researchers assessed the efficacy of venetoclax-based treatments for patients with relapsed/refractory chronic lymphocytic leukemia. This study was presented at the 65th ASH Annual Meeting & Exposition...
02/23/2024
Conference Coverage
Conference Coverage
12/18/2023
Anthony Calabro, MA
In effort to understand the effect of the COVID-19 pandemic among patients with sickle cell disease, researchers compared outcomes and characteristics of hospitalized patients both before and during the...
12/18/2023
Conference Coverage
Conference Coverage
12/12/2023
Anthony Calabro, MA
In their case-controlled study that utilized the National Inpatient Sample 2016-2019 database, researchers set out to examine the relationship between leukemia and sickle cell trait.
12/12/2023
Immunology
virus immune cells
Immunology
12/31/2021
The researchers analyzed 569 patients with multiple myeloma, stratified patients on the basis of their percentage of CD56-expressing clonal MM cells, and then evaluated patient outcomes based on this...
12/31/2021
Tumors
cancer cells
Tumors
12/14/2021
To examine the prognostic value of flow cytometry plus PET/CT scanning for detecting minimal residual disease in patients with multiple myeloma, researchers conducted an observational cohort study of 94...
12/14/2021

Clinical Insights

Podcast
Podcast
08/06/2024
Nirmish R. Shah, MD
In this podcast, Nirmish Shah, MD, discusses patient involvement and the use of patient-reported outcomes in the development of sickle cell disease interventions. Dr Shah’s team presented research on this...
08/06/2024
Video
Video
04/08/2024
Diana Abbott, PhD; Grace Bosma, MS
In this video, Diana Abbott, PhD, and Grace Bosma, MS, discuss their team’s study on the outcomes and intensity of first-line therapy for the treatment of diffuse large B-cell lymphoma (DLBCL) in elderly...
04/08/2024
Conference Coverage
Conference Coverage
01/09/2024
Nirmish R. Shah, MD
In this podcast, Nirmish Shah, MD, discusses using machine learning and leveraging data analysis to make patient predictions about pain and readmission, to use interventions to minimize complications. Dr...
01/09/2024
Conference Coverage
Conference Coverage
12/29/2023
Pinkal Desai, MD
In this podcast, Pinkal Desai, MD, discusses the impact of previous chemotherapy and/or radiation exposure in patients who go on to develop acute myeloid leukemia (AML) or myelodysplastic syndrome (MDS),...
12/29/2023
Conference Coverage
Conference Coverage
12/22/2023
Nirmish R. Shah, MD
In this podcast, Nirmish Shah, MD, discusses an overview, the results, and the preclinical and clinical impact of the study titled Preclinical and Clinical Use of AB1, a DNMT1 Protein Depleter, to...
12/22/2023